EUVIMEDEUVIMED entdecken
Fallbericht

A Rare Case of a Malignant Epithelioid Neoplasm With an Underlying Novel EWSR1::ZBT44 Fusion, Identified on Next-Generation Sequencing (NGS)

Bharat Rekhi iD, Akhil Santosh, Sameer Rastogi

International Journal of Surgical Pathology · 2025

DOI: 10.1177/10668969241246462 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2025. Verfasst von Bharat Rekhi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute University, Mumbai, India. Hauptthemen laut MEDLINE: Soft Tissue Neoplasms, RNA-Binding Protein EWS, Sarcoma, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinicopathological spectrum of undifferentiated round cell sarcomas of bone and soft tissues is expanding after the 5th edition of the WHO classification. A 23-year-old male patient presented with a lump in his left thigh of 3 months’ duration. Radiological examination revealed a well-defined, solid-cystic lobulated, soft tissue lesion in the proximal medial region of his left thigh, measuring 7.7 cm in the largest dimension. The referring diagnosis was an epithelioid sarcoma. Histopathological review of the tumor sections revealed a cellular tumor composed of malignant epithelioid to focally “rhabdoid-like” cells in a variable hyalinized and myxoid stroma with geographic areas of necrosis. In addition, there were areas reminiscent of hemangiopericytomatous vasculature. By immunohistochemistry, the tumor cells were diffusely positive for CD34, focally and distinctly for pan keratin (AE1/AE3). INI1/SMARCB1 and SMARCA4 (BRG1) were diffusely positive (normal). Next-generation sequencing with a wide sarcoma panel revealed EWSR1exon8::ZBT44exon4 fusion. The present example constitutes the first malignant epithelioid tumor with a hemangiopericytomatous growth pattern, exhibiting this rare fusion. The differential diagnoses of this tumor and their corresponding immunohistochemical profile are discussed. This example highlights the value of NGS in unraveling rare fusions and in differentiating these tumors from their several mimics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soft Tissue NeoplasmsRNA-Binding Protein EWSSarcomaOncogene Proteins, FusionHumansMaleYoung AdultHigh-Throughput Nucleotide SequencingBiomarkers, TumorThighTranscription Factors

Stichwörter der Autor:innen

EWSR1EWSR1::ZBT44rare soft tissue tumorsundifferentiated round cell sarcomas

Substanzen

RNA-Binding Protein EWSEWSR1 protein, humanOncogene Proteins, FusionBiomarkers, TumorTranscription Factors

Autor:innen und Institutionen

  • Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute University, Mumbai, India.
  • Department of Medical Oncology, All Indian Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Bharat Rekhi

Zitieren

APA

Rekhi, B., Santosh, A., & Rastogi, S. (2025). A Rare Case of a Malignant Epithelioid Neoplasm With an Underlying Novel EWSR1::ZBT44 Fusion, Identified on Next-Generation Sequencing (NGS). International Journal of Surgical Pathology. https://doi.org/10.1177/10668969241246462

Vancouver

Rekhi B, Santosh A, Rastogi S. A Rare Case of a Malignant Epithelioid Neoplasm With an Underlying Novel EWSR1::ZBT44 Fusion, Identified on Next-Generation Sequencing (NGS). International Journal of Surgical Pathology. 2025. doi:10.1177/10668969241246462

BibTeX
@article{Rekhi2025,
  author = {Rekhi, Bharat and Santosh, Akhil and Rastogi, Sameer},
  title = {A Rare Case of a Malignant Epithelioid Neoplasm With an Underlying Novel EWSR1::ZBT44 Fusion, Identified on Next-Generation Sequencing (NGS)},
  journal = {International Journal of Surgical Pathology},
  year = {2025},
  doi = {10.1177/10668969241246462}
}
Kostenlos starten →